EVAHF (EGF Theramed Health) EV-to-EBIT: -10.22 (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is EGF Theramed Health EV-to-EBIT?

EGF Theramed Health EVAHF EV-to-EBIT is -10.22 as of Jul. 30, 2026. The stock has 3 warning signs investors should review. Among 471 Healthcare Providers & Services companies, EGF Theramed Health ranks worse than 212314.01% on this metric.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, EGF Theramed Health's Enterprise Value is $0.75 Mil. EGF Theramed Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.07 Mil. Therefore, EGF Theramed Health's EV-to-EBIT for today is -10.22.

The historical rank and industry rank for EGF Theramed Health's EV-to-EBIT or its related term are showing as below:

EVAHF' s EV-to-EBIT Range Over the Past 10 Years
Min: -10.41   Med: 0   Max: 0
Current: -10.41

EVAHF's EV-to-EBIT is ranked worse than
100% of 471 companies
in the Healthcare Providers & Services industry
Industry Median: 15.73 vs EVAHF: -10.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. EGF Theramed Health's Enterprise Value for the quarter that ended in Mar. 2026 was $0.84 Mil. EGF Theramed Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.07 Mil. EGF Theramed Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -8.69%.


EGF Theramed Health  (OTCPK:EVAHF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

EGF Theramed Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2026 ) =EBIT / Enterprise Value (Q: Mar. 2026 )
=-0.073/0.84028048
=-8.69 %

EGF Theramed Health's Enterprise Value for the quarter that ended in Mar. 2026 was $0.84 Mil.
EGF Theramed Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EGF Theramed Health EV-to-EBIT Related Terms


EGF Theramed Health EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for EGF Theramed Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EGF Theramed Health EV-to-EBIT Chart

EGF Theramed Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.26 -0.40 -8.64 -5.38 -6.07

EGF Theramed Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.20 -6.07 -5.77 -12.68 -11.56

EVAHF vs VEEV, BTSG, HQY: EV-to-EBIT Comparison

For the Health Information Services subindustry, EGF Theramed Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EGF Theramed Health EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EGF Theramed Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where EGF Theramed Health's EV-to-EBIT falls into.



EGF Theramed Health EV-to-EBIT Calculation

EGF Theramed Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.746/-0.073
=-10.22

EGF Theramed Health's current Enterprise Value is $0.75 Mil.
EGF Theramed Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -10.22 mean?
EGF Theramed Health (EVAHF) has a EV-to-EBIT of -10.22 as of Jul. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EGF Theramed Health and its competitors. According to the industry distribution chart, EGF Theramed Health ranks #999999 out of 471 companies in the Healthcare Providers & Services industry.
Is EGF Theramed Health's EV-to-EBIT too high?
EGF Theramed Health's current EV-to-EBIT is -10.22. Based on the distribution chart, EGF Theramed Health ranks #999999 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does EGF Theramed Health's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EGF Theramed Health ranks #999999 out of 471 companies for EV-to-EBIT. This places EGF Theramed Health in the lower half of its industry. The industry median EV-to-EBIT is 15.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.73, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EGF Theramed Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EGF Theramed Health's current EV-to-EBIT is -10.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EGF Theramed Health stock overvalued right now?
EGF Theramed Health (EVAHF) has a current EV-to-EBIT of -10.22. The current EV-to-EBIT is -10.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For EGF Theramed Health (EVAHF), the current EV-to-EBIT is -10.22 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EGF Theramed Health Business Description

Other Exchanges AUH:GermanyTMED:Canada
Address 609 Granville Street, Suite 1600, P.O. Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EGF Theramed Health Corp is an early-stage development company. It develops products, technologies, and diagnostic tools focused on personalized medical care including research with natural health and wellness products. The products serve the overall goal of improving health and elevating the human condition. It explores many other medical areas including weight loss, skincare and heart disease.